Last updated on September 2010

Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant


Brief description of study

The purpose of this study is to evaluate changes in left ventricular mass and cardiac function in patients with active acromegaly before and after treatment with the growth hormone receptor antagonist pegvisomant for one year.

Clinical Study Identifier: NCT00552851

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Gwendolyn Bender, MD

University of Wuerzburg, Department of Endocrinology
Wuerzburg, Germany
  Connect »